H100 Group AB (“H100” or the “Company”) has been approved for trading on the OTCID Market in the United States.

Trading will commence on 13 August 2025 at 9:30 AM EST (15:30 CEST) under the ticker symbol HOGPF. The listing will be conducted without the issuance of new shares, and trading will take place in U.S. dollars (USD).

The Company’s shares will continue to trade under the ticker H100 on NGM Sweden and GS9 on the Frankfurt OTC.

Contact

Sander Andersen, CEO H100 Group AB
E-mail: sander.andersen@h100.group

About H100 Group

H100 Group AB is a health technology company operating in the health and longevity industry. The company’s business idea is to support providers of health and lifestyle services through AI-powered automation, digital growth tools, and integrated platform solutions, with the goal of helping people live healthy lives to 100 and beyond.
H100 follows a clear growth strategy focused on building a seamless ecosystem where AI integration enhances efficiency and expands service offerings. Growth is further accelerated through strategic acquisitions of key players within its ecosystem, aiming to consolidate and scale the business.
The company is listed on NGM Nordic SME. For more information, visit www.h100.group.

Attachments

H100 Group AB Approved for Trading on OTC US – First Trading Day Set for 13 August 2025

Läs mer på MFN

Ämnen i artikeln


H100 Group

Senast

9,98

1 dag %

−4,04%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån
Senaste aktieanalyserna på Placera
Kollage Analys Ny
Privatekonomi med Placeras expert
Karolina Placera

Karolina Palutko Macéus skriver om allt som har med privatekonomi att göra och hur du kan få mer pengar i plånboken.

Affärsvärlden
AFV

Är du kund hos Avanza? Just nu kan du få en unik rabatt på Affärsvärlden. Afv har 28 år i rad utsetts till Sveriges bästa affärsmagasin i en undersökning med börs-VD:ar, finanschefer, IR-chefer och aktieproffs.

Annons
Introduce

för börsens små- och medelstora företag.

Annons
Investtech

Här hittar du våra artiklar om teknisk analys i samarbete med Investtech.